Adrenocorticotropic hormone-independent Cushing's syndrome

@article{Bourdeau2007AdrenocorticotropicHC,
  title={Adrenocorticotropic hormone-independent Cushing's syndrome},
  author={Isabelle Bourdeau and Antoine Lampron and M{\'a}rcia Helena Soares Costa and Mimi Tadjine and Andr{\'e} Lacroix},
  journal={Current Opinion in Endocrinology, Diabetes and Obesity},
  year={2007},
  volume={14},
  pages={219–225}
}
Purpose of reviewEndogenous Cushing's syndrome is adrenocorticotropic hormone (or corticotropin)-independent in 15–20% of cases. Primary Cushing's syndrome is most often secondary to adrenocortical adenomas or carcinomas, and more rarely to bilateral adrenal hyperplasias. Corticotropin-independent cortisol-producing hyperplasia is caused by micronodular diseases, including primary pigmented nodular adrenocortical disease and nonpigmented micronodular hyperplasia and adrenocorticotropic hormone… Expand
Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).
TLDR
The majority of benign adrenocortical tumors associated with CS are associated with defects of the cAMP signaling pathway, whereas adrenal cancer is linked to aberrant expression of growth factors and germline or somatic mutations of tumor suppressor genes such as TP53. Expand
Clinicopathological correlates of adrenal Cushing's syndrome
TLDR
An update on the rapidly evolving knowledge of adrenal Cushing's syndrome is provided and the clinicopathological correlations of this important disease are discussed. Expand
Republished: Clinicopathological correlates of adrenal Cushing's syndrome
TLDR
An update on the rapidly evolving knowledge of adrenal Cushing's syndrome is provided and the clinicopathological correlations of this important disease are discussed. Expand
Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.
TLDR
An understanding of the dynamics of the HPA axis is necessary to master the diagnosis and differential diagnosis of pituitary-adrenal diseases and giving great insight into its normal control. Expand
Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment
TLDR
The prevalence of subclinical hypercortisolism may be higher than previously reported as more sensitive diagnostic criteria are now recommended and the study of bilateral adrenocorticotropin-independent macronodular Adrenocortical hyperplasia in some familial cases offers a new approach to understanding the spectrum of sub clinical cortisol hypersecretion. Expand
A Gene-Based Classification of Primary Adrenocortical Hyperplasias.
TLDR
The genetics of benign adrenocorticotropin-independent Adrenocortical hyperplasias are discussed, and a new gene-based classification system and diagnostic algorithm is proposed that may aid the clinician in prioritizing genetic testing, screening and counseling of affected, at risk individuals and their relatives. Expand
Systemic therapy of Cushing’s syndrome
TLDR
The following article describes the most prominent substances used for clinical management of CS and gives a systematic overview of safety profiles, pharmacokinetic (PK)-parameters, and regulatory framework. Expand
Corticotropin-independent macronodular adrenal hyperplasia associated with insulinoma.
TLDR
This appears to be the first reported case of corticotropin-independent macronodular adrenal hyperplasia (AIMAH) associated with an insulinoma and may represent a novel endocrine syndrome. Expand
Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
TLDR
Lesions of the adrenal associated with AICS, independently of their GNAS, PRKAR1A, PDE11A, and PDE8B mutation status, have functional abnormalities of cAMP signaling; it is probable that epigenetic events or additional defects of genes involved in this pathway are responsible for this phenomenon. Expand
Analysis of glucose-dependent insulinotropic peptide receptor (GIPR) and luteinizing hormone receptor (LHCGR) expression in human adrenocortical hyperplasia.
TLDR
GIPR and LHCGR overexpression were not identified in the studied cases, thus suggesting that this molecular mechanism is not involved in adrenocortical hyperplasia in patients. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 72 REFERENCES
Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?
TLDR
It is suggested that the clinical screening for the presence of abnormal hormone receptors should be conducted in patients with adrenal Cushing's syndrome and, more particularly, in those with ACTH-independent macronodular adrenal hyperplasia, in the hope of offering medical therapy as an alternative to bilateral adrenalectomy. Expand
Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome.
The mechanism by which cortisol is produced in adrenal Cushing's syndrome, when ACTH is suppressed, was previously unknown and was referred to as being "autonomous." More recently, severalExpand
Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines
TLDR
An intervention could be tried to prevent the development of overt Cushing’s syndrome by suppression of the possible endogenous ligands or by blockade of the receptors that may be aberrantly expressed in his adrenal glands. Expand
Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene.
TLDR
Two different gsp mutations are found in three patients with Cushing's syndrome due to AIMAH, and it is speculated whether they belong to the spectrum of McCune-Albright syndrome or whether these are the first reported cases of AIMah due to gsp mutation. Expand
Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors.
TLDR
In conclusion, this study shows that familial AIMAH could be an autosomal dominantly inherited disorder; aberrant 5-HT4 serotonin and vasopressin receptors can be expressed in familial A IMAH; and phenotypic expression of familial Aimsah could be varied in a same family and more pronounced in female than in male patients. Expand
Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome.
TLDR
The term ACTH-independent used to designate primary adrenal Cushing's syndrome may be inappropriate in some cases of bilateral macronodular adrenal hyperplasia with hypercortisolism and undetectable plasma ACTH levels, because it may be dependent upon ACTH produced within adrenocortical tissue. Expand
Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome.
  • C. Stratakis, L. Kirschner
  • Medicine
  • Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
  • 1998
TLDR
Identification of the molecular defects responsible for bilateral adrenocortical disorders is expected to shed light on many aspects of early adrenal gland differentiation and tumorigenesis. Expand
Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome.
TLDR
Identification of the molecular defects responsible for bilateral adrenocortical disorders is expected to shed light on many aspects of early adrenal gland differentiation and tumorigenesis. Expand
Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome.
TLDR
This study demonstrates that subclinical secretion of cortisol can be regulated via the aberrant function of at least V1-vasopressin, LH/hCG, or 5-HT4 receptors in incidentally identified bilateral macronodular adrenal hyperplasia. Expand
Clinical and Molecular Genetic Studies of Bilateral Adrenal Hyperplasias
TLDR
Recent findings on the clinical and molecular aspects of PPNAD and AIMAH are reviewed, suggesting pathways that affect the cell cycle, adhesion and transcription as possible mediators of adrenocortical hyperplasia. Expand
...
1
2
3
4
5
...